Seer (SEER) Gains from Sales and Divestitures (2023 - 2026)
Seer (SEER) recorded quarterly Gains from Sales and Divestitures of $300082.0 in Q1 2026, down 87.78% quarter-over-quarter from $2.5 million in Q4 2025, and down 70.39% on a YoY basis from $1.0 million in Q1 2025.
Seer (SEER) Gains from Sales and Divestitures (2023 - 2026) Analysis & Trends
Seer's Gains from Sales and Divestitures history runs 4 years deep, the most recent figure standing at $300082.0 for Q1 2026.
- In Q1 2026, Gains from Sales and Divestitures fell 70.39% year-over-year to $300082.0; the TTM figure through Mar 2026 stood at $300082.0 (down 70.39% YoY), while the FY2025 annual figure was $2.5 million, up 127.63% from the prior year.
- Gains from Sales and Divestitures was $300082.0 for Q1 2026 at Seer, down from $2.5 million in the prior quarter.
- In the past five years, Gains from Sales and Divestitures ranged from a high of $2.5 million in Q4 2025 to a low of $300082.0 in Q1 2026.
- Historically, Gains from Sales and Divestitures has averaged $1.2 million across 4 years, with a median of $957746.0 in 2024.
- The sharpest annual moves came in 2025 and 2026: Gains from Sales and Divestitures surged 133.8% in 2025, then slumped 70.39% in 2026.
- A 4-year view of Gains from Sales and Divestitures shows it stood at $510538.0 in 2023, then surged by 111.3% to $1.1 million in 2024, then soared by 127.63% to $2.5 million in 2025, then slumped by 87.78% to $300082.0 in 2026.
- The last three Gains from Sales and Divestitures figures came in at $300082.0 (Q1 2026), $2.5 million (Q4 2025), and $2.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Seer | 95.75 Mn | 95.75 Mn | 982,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 300,082.00 |
| Mar 31, 2026 | 300,082.00 |
| Dec 31, 2025 | 2.46 Mn |
| Dec 31, 2025 | 2.46 Mn |
| Sep 30, 2025 | 2.11 Mn |
| Sep 30, 2025 | 2.11 Mn |
| Jun 30, 2025 | 1.66 Mn |
| Jun 30, 2025 | 1.66 Mn |
| Mar 31, 2025 | 1.01 Mn |
| Mar 31, 2025 | 1.01 Mn |
| Dec 31, 2024 | 1.08 Mn |
| Dec 31, 2024 | 1.08 Mn |
| Sep 30, 2024 | 901,885.00 |
| Sep 30, 2024 | 901,885.00 |
| Jun 30, 2024 | 838,948.00 |
| Jun 30, 2024 | 838,948.00 |
| Mar 31, 2024 | 638,004.00 |
| Mar 31, 2024 | 638,004.00 |
| Dec 31, 2023 | 510,538.00 |
| Dec 31, 2023 | 510,538.00 |